Evaluation of the Annual Sales of Acetylsalicylic Acid, Metamizole and Paracetamol in North Cyprus: Emphasizing the Wide Paracetamol Use


Affiliations

  • Eastern Mediterranean University, Faculty of Pharmacy, Famagusta, 99628, Turkey

Abstract

Background: Among the analgesic-antipyretic agents acetylsalicylic acid, metamizole and paracetamol are commonly used. Objective: The aim of this study was to analyse the sales of acetylsalicylic acid, metamizole and paracetamol in Northern Cyprus from the pharmaceutical wholesale companies during one year period. Methods: We collected the data of annual drug delivery to hospitals and community pharmacy stores between 1st September 2013 and 31st August 2014 from the five most prevalent pharmaceutical wholesale companies that serve in North Cyprus. Results: We noticed that oral administration routes of these three molecules were very dominant with 92.88%. Paracetamol was the most preferred with a total annual sale of 117668 boxes (65.25%). 500 mg paracetamol with 65 mg caffeine was the highest among the combined drug formulations of paracetamol (45236 boxes). Metamizole was ranked the second with 18.65%. Drug formulations containing only acetylsalicylic acid were dispensed 24909 boxes, whereas tablets higher than 325 mg were only 5232 boxes. Conclusions: Our findings showed that paracetamol was the most preferred analgesic, anti-pyretic agent compared to acetylsalicylic acid and metamizole in North Cyprus. Our results also pointed out that, the use of acetylsalicylic acid for prophylactic purposes like thromboembolic event prevention was higher than analgesic, anti-pyretic and antiinflammatory purposes.

Keywords

Analgesic, Pain, Paracetamol, Pharmacy Practice

Full Text:

References

Merskey H, Bogduk N. “Part III: Pain terms, a current list with definitions and notes on usage” Classification of Chronic Pain, Second Edition, IASP Task Force on Taxonomy. Seattle: IASP Press; 1994. p. 209–14.

The Centers for Disease Control and Prevention (CDC). Definitions of Symptoms for Reportable Illnesses. National Center for Emerging and Zoonotic Infectious Diseases. Division of Global Migration and Quarantine. 2014. p. 1

Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003; 110(5-6):255–8. https://doi.org/10.1016/ S0049-3848(03)00379-7

Hankey GJ. The benefits of aspirin in early secondary stroke prevention. Lancet. 2016; 388(10042):312–4. https:// doi.org/10.1016/S0140-6736(16)30511-6

Friis S, Riis AH, Erichsen R, Baron JA, Sørensen HT. Lowdose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case-control study. Ann Intern Med. 2015; 163(5):347–55. https://doi.org/10.7326/M15-0039 PMid:26302241

Harding JJ. Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev. 2002; 1(3):465–79. https:// doi.org/10.1016/S1568-1637(02)00012-0

Jasiecka A, Maślanka T, Jaroszewski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci. 2014; 17(1):207– 14. https://doi.org/10.2478/pjvs-2014-0030 PMid:24724493

Fehintola FA, Ganiyu AA. Prescriptions involving analgesic drugs at a secondary health facility in Ibadan, Nigeria. Ann Ib Postgrad Med. 2008; 6(2):34–8. PMid:25161452 PMCid:PMC4110997

Garcia S, Canoniero M, Lopes G, Soriano AO. Metamizole use among Hispanics in Miami: report of a survey conducted in a primary care setting. South Med J. 2006; 99(9):924– 6. https://doi.org/10.1097/01.smj.0000233020.68212.8f PMid:17004525

Hinz B, Brune K. Paracetamol and cyclooxygenase inhibition: Is there a cause for concern? Ann Rheum Dis.2012; 71(1):20–5. https://doi.org/10.1136/ard.2011.200087 PMid:22039164

Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: Mechanism of action, applications and safety concern. Acta Pol Pharm.2014; 71(1):11–23. PMid:24779190

Alloui A, Chassaing C, Schmidt J, Ardid D, Dubray C, Cloarec A, Eschalier A. Paracetamol exerts a spinal, tropisetronreversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol. 2002; 443(1-3):71–7 https://doi.org/10.1016/S0014-2999(02)01578-9

Bujalska M. Effect of nitric oxide synthase inhibition on antinociceptive action of different doses of acetaminophen. Pol J Pharmacol. 2004; 56(5):605–10. PMid:15591650

Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf. 2002; 11(8):687–93. https://doi.org/10.1002/pds.732 PMid:12512245

Eccles R. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther. 2006; 31(4):309–19. https://doi.org/10.1111/j.13652710.2006.00754.x PMid:16882099

Ajuoga E, Sansgiry SS, Ngo C, Yeh RF. Use/misuse of overthecounter medications and associated adverse drug events among HIV-infected patients. Res Social Adm Pharm. 2008; 4(3):292–301. https://doi.org/10.1016/j. sapharm.2007.08.001 PMid:18794039

Lanas A, Gargallo CJ. Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective. J Gastroenterol. 2015; 50(6):626–37. https://doi.org/10.1007/s00535-015-1038-3 PMid:25595209

Blitz J. Buffered aspirin and oral salicylate. In: Sinatra RS, Jahr JS, Pitchford JMW. The Essence of Analgesia and Analgesics. New York: Cambridge University Press, 2011.p. 252–5

Sarganas G, Buttery AK, Zhuang W, Wolf IK, Grams D, Rosario AS, Scheidt-Nave C, Knopf H. Prevalence, trends, patterns and associations of analgesic use in Germany. BMC Pharmacol Toxicol. 2015; 16:28. https://doi.org/10.1186/ s40360-015-0028-7 PMid:26428626 PMCid:PMC4591581

Zhou Y, Boudreau DM, Freedman AN. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf. 2014; 23(1):43–50. https://doi.org/10.1002/pds.3463 PMid:23723142

Konturek PC, Kania J, Gessner U, Konturek SJ, Hahn EG, Konturek JW. Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy. Eur J Pharmacol. 2004; 506(2):169–77. https://doi.org/10.1016/j.ejphar.2004.10.048 PMid:15588738

Arellano F, Sacristán JA. Metamizole: reassessment of its therapeutic role. Eur J Clin Pharmacol. 1990 ;38(6):617–9. https://doi.org/10.1007/BF00278592 PMid:2197099

Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M, Konzen C, Kreutz R, Garbe E. Metamizoleinduced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.Eur J Clin Pharmacol. 2015; 71(2):219–27. https://doi.org/10.1007/s00228-014-1777-8 PMid:25378038

Patel KD. Acetaminophen oral and rectal. In: Sinatra RS, Jahr JS, Pitchford JMW. The Essence of Analgesia and Analgesics. New York, Cambridge University Press, 2011: 252–5.

Prescott LF. Paracetamol: past, present, and future. Am J Ther. 2000; 7(2):143–7. https://doi.org/10.1097/00045391200007020-00011 PMid:11319582

Brune K, Renner B, Tiegs G. Acetaminophen/paracetamol: A history of errors, failures and false decisions. Eur J Pain. 2015; 19(7):953–65. https://doi.org/10.1002/ejp.621 PMid:25429980

Mattia A, Coluzzi F. What anesthesiologists should know about paracetamol (acetaminophen). Minerva Anestesiol.2009; 75(11):644–53. PMid:19881460

Dart RC, Bailey E. Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy. 2007; 27(9):1219–30. https://doi.org/10.1592/phco.27.9.1219 PMid:17723075

Marzuillo P, Guarino S, Barbi E. Paracetamol: a focus for the general pediatrician. Eur J Pediatr. 2014; 173(4):415–25. https://doi.org/10.1007/s00431-013-2239-5 PMid:24374658

Cazacu I, Mogosan C, Loghin F. Safety issues of current analgesics: an update. Clujul Med. 2015; 88(2):128–36.https://doi.org/10.15386/cjmed-413 PMid:26528060 PMCid:PMC4576793

Saengcharoen W, Buasri N, Khantapokha B, Lerkiatbundit S. Public knowledge and factors associated with inappropriate analgesic use: a survey in Thailand. Int J Pharm Pract. 2016; 24(1):22–9. https://doi.org/10.1111/ijpp.12201 PMid:26149088

Palmer H, Graham G, Williams K, Day R. A riskbenefit assessment of paracetamol (acetaminophen) combined with caffeine. Pain Med. 2010; 11(6):951–65.https://doi.org/10.1111/j.1526-4637.2010.00867.x PMid: 20624245

Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence. N Engl J Med. 1990; 322(6):364–9. https://doi.org/10.1056/ NEJM199002083220604 PMid:2242106

Kostrubsky SE, Sinclair JF, Strom SC, Wood S, Urda E, Stolz DB, Wen YH, Kulkarni S, Mutlib A. Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes. Toxicol Sci. 2005; 87(1):146–55. https://doi.org/10.1093/toxsci/kfi211 PMid:15933229


Refbacks

  • There are currently no refbacks.